However, this certainly does not seem to hold true for ‘metaplastic’ type squamous cell and adenosquamous carcinomas arising in glandular organs where adenocarcinomas are far more common.

The overall survival benefit was consistent in both histologic subgroups (squamous-cell carcinoma and adenocarcinoma [including adenosquamous carcinoma]). Progression-free survival was also longer ...

Adenocarcinoma is treated in the same way as squamous cell cancer of the cervix. Adenosquamous cancers are tumours that have both squamous and glandular cancer cells. This is a rarer type of cervical ...

The impact of a genomic sequencing classifier (GSC) on clinical decision making in patients with a high-risk lung nodule. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I. This ...

Efficacy and safety of nab-paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment for patients with advanced gastric cancer: A single institutional experience. This is ...

In this trial involving patients with stage IA1 (lymphovascular invasion), IA2, or IB1 cervical cancer and a histologic subtype of squamous-cell carcinoma, adenocarcinoma, or adenosquamous ...

A new case report was published in Oncotarget's Volume 15 on October 11, 2024, entitled "A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to ...

The team identified, in preclinical models, therapeutic targets for adenosquamous cancer of the pancreas (ASCP) and pinpointed already available cancer inhibitors originally designed for other ...